AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Upcoming Stock Splits for August 18-22: Salarius, Entero, Chanson, LanzaTech, GIBO
ByAinvest
Sunday, Aug 17, 2025 8:29 pm ET1min read
Several companies are undergoing stock splits this week, including Salarius Pharmaceuticals, Entero Therapeutics, Chanson International Holding, LanzaTech Global, and GIBO Holdings. These splits are either traditional or reverse, aimed at broadening a stock's accessibility or maintaining compliance with exchange rules.
Several companies are undergoing stock splits this week, including Salarius Pharmaceuticals, Entero Therapeutics, Chanson International Holding, LanzaTech Global, and GIBO Holdings. These splits are either traditional or reverse, aimed at broadening a stock's accessibility or maintaining compliance with exchange rules.Salarius Pharmaceuticals (NASDAQ: SLRX) announced a 1-for-15 reverse stock split, set to take effect at 5:00 p.m. Eastern Time on August 15, 2025. This move is intended to regain compliance with the $1.00 minimum closing bid price required for continued listing on the Nasdaq Capital Market. The reverse stock split will reduce the number of shares from approximately 7.6 million to approximately 509,000 shares [2].
Entero Therapeutics (NASDAQ: ENTR) is also undergoing a reverse stock split, with details yet to be announced. Chanson International Holding (NASDAQ: CHAN) and LanzaTech Global (NASDAQ: LTCH) are expected to follow suit with their own stock splits in the coming weeks. GIBO Holdings (NASDAQ: GIBO) has not yet disclosed specific details about its upcoming stock split.
Reverse stock splits are a common strategy used by companies to increase the price per share, potentially making the stock more attractive to investors. However, they can also dilute the number of shares outstanding, which can affect the overall value of the company. Investors should carefully consider the implications of these splits before making any investment decisions.
References:
[1] AInvest. (2025, August 17). Cardano ADA Breaks Downtrend Hints At 176 Rally. https://www.ainvest.com/news/cardano-ada-breaks-downtrend-hints-176-rally-1-84-2508/
[2] Salarius Pharmaceuticals. (2025, August 14). Salarius Pharmaceuticals Announces 1-for-15 Reverse Stock Split. https://www.biospace.com/press-releases/salarius-pharmaceuticals-announces-1-for-15-reverse-stock-split
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet